Product
Help
Pricing
About
Jobs
Log in
Get started
Keyword
Add to collection
motor function decline
Description:
A progressive reduction in movement abilities associated with aging, neurological disease, or other health conditions.
Related topics:
Parkinson's Disease Mechanisms and Treatments (15%),
Amyotrophic Lateral Sclerosis Research (10%)
OpenAlex ID:
keywords/motor-function-decline
Motor control and aging: Links to age-related brain structural, functional, and biochemical effects
2009
·
Rachael D. Seidler
, Jessica A. Bernard
, et al.
·
Neuroscience & Biobehavioral Reviews
·
1,945
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
2009
·
C. Warren Olanow
, Olivier Rascol
, et al.
·
New England Journal of Medicine
·
922
PDF
Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data
2013
·
Sarah J Tabrizi
, Rachael I Scahill
, et al.
·
The Lancet Neurology
·
875
Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis.
1995
·
M E Ripps
, G W Huntley
, et al.
·
Proceedings of the National Academy of Sciences
·
745
A deep learning approach for Parkinson’s disease diagnosis from EEG signals
2018
·
Shu Lih Oh
, Yuki Hagiwara
, et al.
·
Neural Computing and Applications
·
647
Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis
2010
·
Sarah J Tabrizi
, Rachael I Scahill
, et al.
·
The Lancet Neurology
·
621
The Trajectory of Gait Speed Preceding Mild Cognitive Impairment
2010
·
Teresa Buracchio
, Hiroko H. Dodge
, et al.
·
Archives of Neurology
·
584
PDF
Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data
2011
·
Sarah J Tabrizi
, Ralf Reilmann
, et al.
·
The Lancet Neurology
·
558
Observational study of spinal muscular atrophy type I and implications for clinical trials
2014
·
Richard S. Finkel
, Michael P. McDermott
, et al.
·
Neurology
·
547
PDF
Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models
2011
·
Xiyun Chai
, Su Wu
, et al.
·
Journal of Biological Chemistry
·
368
S erum immune markers and disease progression in an incident P arkinson's disease cohort ( ICICLE‐PD )
2016
·
Caroline H. Williams‐Gray
, Ruwani Wijeyekoon
, et al.
·
Movement Disorders
·
334
PDF
Loss of motor function in preclinical Alzheimer’s disease
2011
·
Aron S Buchman
, David A Bennett
·
Expert Review of Neurotherapeutics
·
328
Trial of celecoxib in amyotrophic lateral sclerosis
2006
·
Merit E. Cudkowicz
, Jeremy M. Shefner
, et al.
·
Annals of Neurology
·
310
2001–2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease?
2011
·
The LADIS Study Group
·
Cerebrovascular Diseases
·
301
Association Between Late-Life Social Activity and Motor Decline in Older Adults
2009
·
Aron S. Buchman
, Patricia A. Boyle
, et al.
·
Archives of Internal Medicine
·
292
Prospective cohort study of spinal muscular atrophy types 2 and 3
2012
·
Petra Kaufmann
, Michael P. McDermott
, et al.
·
Neurology
·
291
PDF
Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline
2008
·
L. C. Silbert
, C. Nelson
, et al.
·
Neurology
·
267
PDF
A double-blind, placebo-controlled randomized clinical trial of α-tocopherol (vitamin E) in the treatment of amyotrophic lateral sclerosis
2001
·
Claude Desnuelle
, Michel Dib
, et al.
·
Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
·
266
Impact of sustained deprenyl (selegiline) in levodopa‐treated Parkinson's disease: A randomized placebo‐controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial
2002
·
Ira Shoulson
, David Oakes
, et al.
·
Annals of Neurology
·
261
NCL diseases — clinical perspectives
2013
·
Angela Schulz
, Alfried Kohlschütter
, et al.
·
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
·
259
PDF
Clarifying lysosomal storage diseases
2011
·
Mark L. Schultz
, Luis Tecedor
, et al.
·
Trends in Neurosciences
·
254
Aging: An important factor for the pathogenesis of neurodegenerative diseases
2008
·
Tahira Farooqui
, Akhlaq A. Farooqui
·
Mechanisms of Ageing and Development
·
253
Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial
2013
·
Merit E Cudkowicz
, Leonard H van den Berg
, et al.
·
The Lancet Neurology
·
248
Compensatory mechanisms in the aging motor system
2006
·
Nick S. Ward
·
Ageing Research Reviews
·
240
Sodium Valproate Exerts Neuroprotective EffectsIn Vivothrough CREB-Binding Protein-Dependent Mechanisms But Does Not Improve Survival in an Amyotrophic Lateral Sclerosis Mouse Model
2007
·
Caroline Rouaux
, Irina Panteleeva
, et al.
·
Journal of Neuroscience
·
226
PDF
Show more works
View as search
Works count:
1,275
Citation count:
33,040
Year
Topic
Type